Effects of Phaseolus vulgaris extract on weight and metabolism
Official title: Single-centre, Prospective, Randomized, Placebo-controlled, Single-blind Clinical Trial to Evaluate the Efficacy of a Food Supplement Based on Phaseolus Vulgaris L. Dry Extract on the Modulation of Weight and Metabolic Parameters
Run by IBSA Farmaceutici Italia Srl · NCT06193577 · Data updated 2026-11-12
This study is testing if an extract from kidney beans can help people lose weight and improve their metabolism over 12 weeks compared to a placebo.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | Men only |
| Enrollment | 60 (estimated) |
| Sponsor | IBSA Farmaceutici Italia Srl Industry-sponsored |
| Locations | 1 site (Catania, Catania) |
| Status | Recruiting |
| Started | November 8, 2023 |
| Main results expected | June 30, 2025 |
| Study ends | June 30, 2025 |
| Registry record updated | January 8, 2025 |
| Trial ID | NCT06193577 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are male adults aged 18 to 60 with a BMI between 25 and 35 who have stable body weight and consume three meals a day.
✕Probably not a fit
Patients with diabetes, significant smoking or alcohol consumption, or a history of eating disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the efficacy of Phaseolus vulgaris L. dry extract in promoting weight loss and improving metabolic parameters over a 12-week period. It is a monocentric, prospective, randomized, single-blind study comparing the effects of the extract against a placebo. Participants will be required to maintain their usual diet and lifestyle throughout the study to ensure accurate results.
Why it matters
Potential benefit: If successful, this study could provide a natural supplement option for individuals seeking to lose weight and improve their metabolic health.
How similar studies have gone: While there have been studies on natural extracts for weight loss, the specific use of Phaseolus vulgaris L. dry extract in this context is less common, making this approach somewhat novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male subjects aged between 18 and 60 years * BMI between 25 and 35 kg/m2 * Habitual consumption of three main meals a day * Stable body weight during the 3 months prior to enrollment * Commitment to adhere to the diet and avoid the use of other weight loss products during the study * Commitment not to change lifestyle significantly for the entire duration of the study. * Signing of informed consent Exclusion Criteria: * Hypergonadotropic hypogonadism and hypogonadotropic hypogonadism * Diabetes mellitus * Smoking \> 10 cigarettes/day * Alcohol \> 2 alcohol units/day (equal to 24 g of ethanol) * History of eating disorders during the 12 months prior to enrollment * Use of any drug or product to treat obesity (e.g. meal replacements) * Presence of acute or chronic gastrointestinal diseases * Active use of drugs that could influence the functions: gastrointestinal (e.g. laxatives, etc.), insulin (insulin sensitizers, etc.) and/or testicular (hormones, substances that influece testosterone production * Known sensitivity to the ingredients of the preparation * Any other clinical condition judged by the investigator to be incompatible with participation in the trial
Where it's running
-
A.O.U. Policlinico "G. Rodolico - San Marco"
Catania, Catania, Italy Recruiting
Study contacts
- Principal investigator: Aldo Calogero, Prof. — Università di Catania
- Study coordinator: Carmelo Gusmano, MD
- Email: carmelo.gusmano@yahoo.it
- Phone: +393891136444
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
15-year outcomes after sleeve gastrectomy in France
This study looks at how people who had sleeve gastrectomy have fared over 15 years to see long-term weight changes and health effects.
-
Do GLP-1 medicines affect breastmilk production and milk quality after pregnancy
This study will test whether weight loss from injected GLP-1 receptor agonists changes how much milk moms produce or the nutritional makeup of their breast milk.
-
Personalized 26-week program to help keep weight off
This 26-week program tests whether tailored messages, weekly check-ins and weighing, and optional health coaching help adults who recently lost at least 7% of their weight keep it off.
-
HRS9531 PK in adults with different liver function
This Phase 1 study tests how HRS9531 behaves in the body and whether it is safe in people with mild, moderate liver impairment and those with normal liver function.
-
Fasted versus fed aerobic exercise for weight loss and heart health
This 16-week program will see if doing aerobic exercise before breakfast (fasted) versus after eating helps adults with overweight or obesity lose more weight and improve heart-related measures.
-
Multi-strain Bacillus probiotic for cesarean-delivered newborns
This study tests whether daily multi-strain Bacillus spore probiotics help cesarean-born newborns grow better and have fewer tummy troubles by supporting a healthier gut microbiota.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.